Axa S.A. Outlook Therapeutics, Inc. Transaction History

Axa S.A.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$1.27 - $2.23 $184,166 - $323,378	-145,013 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$2.12 - $2.76 $354,654 - $461,720	-167,290 Reduced 53.57%	145,013 $315,000
Q2 2021 Aug 13, 2021	SELL	$1.78 - $2.76 $181,009 - $280,667	-101,691 Reduced 24.56%	312,303 $778,000
Q1 2021 May 14, 2021	BUY	$0.94 - $3.31 $389,154 - $1.37 Million	413,994 New	413,994 $931,000

31.5K

Ticker OTLK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 226,144,992
Market Cap $1.17B
Description
Outlook Therapeutics, Inc., a late clinical-stage biopharmaceutical company, focuses on developing and commercializing monoclonal antibodies for various ophthalmic indications. Its lead product candidate is ONS-5010, an ophthalmic formulation of bevacizumab product candidate that is in Phase-III clinical trial for the treatment of wet age-relate...

Get notified when there are updates to the investment portfolio of Axa S.A., based on Form 13F filings with the SEC.

Stay updated on Axa S.A. with notifications on news.